# Biomarkers in Patients With Advanced Rhabdomyosarcoma

> **NCT01668095** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 10 (estimated)

## Conditions studied

- Adult Rhabdomyosarcoma
- Childhood Alveolar Rhabdomyosarcoma
- Childhood Embryonal Rhabdomyosarcoma
- Previously Treated Childhood Rhabdomyosarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Recurrent Childhood Rhabdomyosarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage IV Adult Soft Tissue Sarcoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01668095
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668095, "Biomarkers in Patients With Advanced Rhabdomyosarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01668095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
